Archive | Artificial Intelligence (AI) RSS feed for this section

Introducing the Innovator’s Pitch Challenge Finalists!

7 Jan

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claireLife Science Nation (LSN)’s Inaugural Healthtech Partnering Week launches next week, which means the Innovator’s Pitch Challenge (IPC) is on! The IPC is an opportunity for early-stage, fundraising CEOs to pitch directly to a panel of judges, who follow up with a live Q&A session.

How does it work? The finalist companies deliver pitching materials, including a comprehensive slide deck, executive summary, and a long form pitch video to be hosted on a dedicated webpage the judges review prior to their live session. Sessions are split up by sectors and are designed to match up companies with investors actively seeking opportunities in their space. During the live session, companies deliver a brief short form pitch, which is then followed by a Q&A period with the judges.

Each event sees an incredible line up of early-stage companies delivering promising tech to advance life science and healthcare. LSN is proud to host this powerful meeting of the minds.

Innovator’s Pitch Challenge Finalists

J.P. Morgan Week Update: The Perfect Venue to Launch LSN Healthtech Partnering Week

7 Jan

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series

It’s that time of year again! J.P. Morgan’s Annual Healthcare Conference has spawned countless concurrent healthcare conferences taking advantage of the influx of industry professionals eager to network and make deals for nearly forty years. The Redefining Early-Stage Investments (RESI) conference series has been a popular addition for several years, and it seemed the obvious choice when we looked to launch our own Healthtech Partnering Week.

Over the past ten months, as many industries slowed down, Life Science Nation (LSN)’s partnering events have ramped up, delivering an increased number of one-on-one meetings between fundraising early-stage companies and investors. The metrics speak for themselves, as we’ve seen an average of 1400+ meetings take place over three days of digital partnering, proving that digital partnering works with investors pulling the deal-making trigger. The proof-of-concept, preclinical and clinical trial money is flowing.

Learn more about Healthtech Partnering Week and join the 500+ investors.

What’s the difference?

MATCHING LSN’s customized partnering system enables fundraising CEOs, investors, and strategic partners to seek opportunities based on several search criteria, most importantly including product fit and stage of development, helping attendees avoid wasted meetings, which can amount to more than half the meetings booked at standard partnering conferences. LSN’s database of thousands of investors and start-ups provides detailed profiles that help attendees increase their chances of success by matching with the best partners for them.

MESSAGING LSN has interviewed thousands of investors in order to learn what their criteria are for taking a meeting and engaging with an investment prospect. The trends we found have been written into a book (FREE PDF COPY) designed to help the scientist-entrepreneur understand how to get their branding and messaging straight. This starts with a cogent 5–7-word tagline, a lucid 6-7-sentence elevator pitch, and a one-page data sheet that succinctly presents all relevant information a potential investor would need at first glance. Finally, tell your unique story through a two-page executive summary and elaborate on your technology in a 10–12-page pitch deck.

FOLLOW-UP Partnering is an extremely competitive contact sport. You need to get your company and message above the noise. Investors and strategic partners are inundated with meeting requests, and if you do not have a compelling tactical plan to go after and secure meetings, you run the risk of getting only 4-6 meetings, instead of 15-20+. It’s a numbers game – we don’t make the rules, but we know how to play by them.

LSN has developed a 4-step follow-up process. The concept of follow-up stops most early-stage entrepreneurs in their tracks and thus limits their interaction with targeted partners. We walk a fundraising CEO through all these issues and set them on the right path through our content, bootcamps and seminars. Preparing CEOs for partnering success is rarely given enough attention, and LSN is passionate about using its insight to help deal-flow to promising teams and their tech.

Check out more tips on partnering and a tutorial of the LSN system. There’s still time to register for events at Healthtech Partnering Week. Don’t miss out!

Introducing the 4D Meets AI Panelists

3 Dec

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series

4D Meets AI is partnering conference designed for innovators and investors on the cutting-edge of AI technology applications in life science and healthcare. In addition to Life Science Nation (LSN)’s premier partnering platform, 4D Meets AI delivers insight via pre-recorded panel discussions on the early-stage ecosystem from both investors and founders. The panel agenda features active and engaging investors and industry leaders developing creative healthcare solutions through the power of AI technology.

Sign up for 4D Meets AI at LSN’s Healthtech Partnering Week, January 11-15, 2021, and get to know key industry players advancing the future of the 4Ds – Drugs, Devices, Diagnostics, and Digital Health.

Drugs: Applications
Exploring Drug Discovery and Development through the Lens of AI Technology Enabling Innovation

Moderator: Christopher Locher, PhD, Founder & CEO, Versatope Therapeutics
Panelists:

  • Sean Ekins, PhD, Founder & CEO, Collaborations Pharmaceuticals
  • David Harel, MBA, Co-Founder & President, CytoReason
  • Laura Towart, Founder & CEO, MyPersonalTherapeutics
  • Jonathan Ward, MBA, Co-Founder & CEO, Genome Biologics

Drugs: Investors
Investors Working in & Seeking Therapeutic Opportunities

Moderator: Ronjon Nag, PhD, Founder & Managing Director, R42 Group
Panelists:

  • Kan Chen, PhD, Principal, Qiming Venture Partners
  • Weiyong Sun, MD, PhD, MBA, Senior Director, Searching and Evaluation, Global Business Development, Daiichi Sankyo Group

Additional Panelists to be Announced

Devices: Applications
Sensors, Wearables & More Enabling Patient Monitoring & Disease Management

Moderator: John Cromwell, MD, CMO, Entac Medical
Panelists:

  • Maria Arvanitidou, Head, Corporate Development & Partnerships, Sentio Solutions
  • Hadeel Ayoub, PhD, Founder & CTO, BrightSign Technology
  • Loewen Cavill, CEO, AuraBlue
  • Anthony Ortiz, Founder & CEO, Fitly

Devices: Investors
Medical Device Investors on the State of the Market

Moderator: Geoff Pardo, MBA, Partner, Gilde Healthcare
Panelists:

  • Amy Belt Raimundo, MBA, Managing Director, Kaiser Permanente Ventures
  • James Eadie, MD, Partner, Santé Ventures
  • Bryan Grulke, MBA, Partner, Volcano Capital

Additional Panelists to be Announced

Diagnostics: Applications
Fast, Accurate & Accessible Disease Detection

Moderator: Michael Abramoff, MD, PhD, Founder & Executive Chairman, Digital Diagnostics
Panelists:

  • Chris Fernandez, Co-Founder & CEO, EnsoData
  • Hui Li, PhD, Co-Founder & CEO, Singularity AI
  • Geetha Manjunath, PhD, Founder & CEO, Niramai Health Analytix

Additional Panelists to be Announced

Diagnostics: Investors
Investors Seeking Diagnostic Innovation
Moderator to be Announced

Panelists:

  • Lavanya Bhamidipati, MBA, Investment Associate, InHealth Ventures
  • Jun Deng, PhD, Investment Partner, Joyance Partners
  • Steve Seuntjens, MiM, Partner, Personal Health Solutions
  • Prachi Sinha, MBA, Healthcare Investment Head, Axilor Ventures

Additional Panelists to be Announced

Digital Health: Applications
Technologies Aiding Clinical Optimization & Patient Treatment
Moderator: Michelle Perugini, PhD, CEO, Presagen
Panelists:

  • Zack Dvey-Aharon, PhD, Co-Founder & CEO, AEYE Health
  • Umar Naeem Ahmad, Co-Founder & CEO, Abtrace
  • Mylene Yao, MD, Co-Founder & CEO, Univfy
  • Maya Zlatanova, MIB, Co-Founder & CEO, FindMeCure

Digital Health: Investors
How Digital Health Companies Can Stand Out

Moderator: Yizhen Dong, MBA, Partner, Global Founders Capital
Panelists:

  • Hamzeh Abdul-Hadi, Principal, Hikma Ventures
  • Gary Gershony, MD, General Partner, Baymed Venture Partners
  • Joseph Mocanu, PhD, Managing Partner, Verge HealthTech Fund
  • Julianne Roseman, Venture Associate, Plug and Play Ventures

A Conversation with Helena Cowley, CEO of Oxidien Pharmaceuticals

3 Dec

By Rory McCann, Marketing Manager & Conference Producer, LSN

Helena Cowley, MS, MBA is CEO of Oxidien Pharmaceuticals, a therapeutics company mitigating kidney stone disease by using enzyme compounds to treat secondary hyperoxaluria. We recorded our chat about the early days of Oxidien and how they’ve navigated the fundraising landscape. We discuss conferences, networking, and tools to give early-stage companies an edge when meeting with strategic partners.

To learn more about RESI and Life Science Nation’s premier partnering events this September, visit www.resipartneringweek.com. Digital RESI Partnering Week September super early bird rates apply until July 23, so sign up today to start meeting with investors and strategic partners to jumpstart your 2021 fundraising goals!

 

Why Failure is Falling Upwards ​​​​​​​– Learn from Entac Medical Founder, Buddy Lyons, and Find Out How RESI became Part of the Success Story

19 Nov

By Rory McCann, Marketing Manager & Conference Producer, LSN

Failure is an unwelcome companion on the entrepreneurial journey, and one most founders avoid at all costs. To Buddy Lyons, Founder and CEO of Entac Medical, failure (or the threat of it) can play an integral role in a company’s development, growth, and eventual success. Entac Medical is developing non-invasive devices for diagnosis, particularly to surgical patients. Hear their story and listen to my conversation with Buddy about the earliest days of Entac, and what got them through the most trying times.

Boost Your Exposure at Healthtech Partnering Week – Apply for the Innovator’s Pitch Challenge (IPC)

19 Nov

By Claire Jeong, Vice President of Investor Research, Asia BD, LSN

claireWe are now accepting applications for the Innovator’s Pitch Challenge at Healthtech Partnering Week, taking place January 11-15, 2021.

The Innovator’s Pitch Challenge (IPC) is an opportunity for start-ups to boost their exposure and showcase their technology to conference attendees, particularly investors. Each company will be provided with a dedicated landing page on our virtual agenda, which will include their pitch video, slide deck, executive summary, and any other materials companies wish to feature on their page. In addition, the companies pitch to a panel of judges featuring active investors and prominent industry experts, and participate in a live Q&A. These sessions will provide valuable insights and feedback, as well as build connections between fundraising founders and potential strategic partners.

If you are a fundraising CEO, you do not want to miss out on this opportunity.

Example of a Company’s Landing Page

New Sponsoring Opportunities at LSN’s Quarterly Healthtech Partnering Week

12 Nov

By Dennis Ford, Founder and CEO, Life Science Nation (LSN); Creator, Redefining Early Stage Investment (RESI) Conference Series, 4D Meets AI Conference, and Longevity, Health & Innovation Conference; Architect, Focus on Cures Accelerator; Owner, Boston Innovation Capital (BIC); Member, SPIC/FINRA Advisory Firm

New Sponsorship Program

Life Science Nation (LSN) has built a sourcing and funding global superstructure featuring elite global technology assets and the investors, Pharma and channel partners who seek them. The international infrastructure consists of early-stage life science buyers and sellers, each with updated curated data profiles that are matched up at LSN’s dedicated partnering events. In 2021, these partnering events will join forces to become a global quarterly Healthtech Partnering Week, featuring RESI, 4D Meets AI, as well as Longevity, Health & Innovation partnering conferences. These events will take place in conjunction with global life science hubs, enabling fundraising CEOs to leverage the partnering system as part of a global capital raising campaign. Sponsorship at these events help companies gain unprecedented visibility into the early-stage life science community, and also leverage LSN’s close-knit network of key decision-makers to make promising connections with future clients and strategic partners. The sponsorship program is designed to help organizations increase global exposure through high visibility branding and messaging, target and source assets and strategic partnerships, advertise products and services through programming and direct contact with industry leaders. To learn more about sponsorship opportunities, download our sponsorship brochure.

The Digital Experience: 2020-2021

The Covid-19 pandemic has challenged the global economy and business climate, but LSN has not slowed down. On the contrary, LSN has accelerated since March 2020 through its focus on deal-making. LSN partnering conferences are experiential, interactive, and focus on building relationships and successful transactions. LSN stands out among other educational life science networks for this mission. LSN’s continued mission has been to connect buyers and sellers to move the needle in the early-stage life science partnering arena. Partnering is neither a trend nor conference sideshow, rather an essential matching exercise that needs curated profiles of both the buyer and the seller, and an integrated search feature that can match companies based on mutual fit.

Matching Buyers and Sellers Together

LSN matches buyers and sellers based on stage of development and product fit through curating detailed up-to-date profiles of every constituent of the two groups. This method enables efficient partnering at LSN events and avoids empty tables and ill-fitting meetings. Matching requires profile curation and detailed database management, therefore, a large volume of LSN resources go towards maintaining and constantly improving this imperative feature. In addition to efficient matching, LSN offers educational resources available to fundraising executives including LSN CEO, Dennis Ford’s book, The Life Science Executive Fundraising Manifesto which guides scientist-entrepreneurs through the concepts of building branding and messaging. Additional resources include free tutorials and webinars aimed at preparing CEOs to book meetings with investors effectively, which includes adroit messaging and a 4-step follow-up process, which has been proven to advance the needle from 4-6 meetings to 12-20 meetings. Fundraising is a numbers game and understanding how to get the most of out of these global partnering events is the key to a successful capital raise.

Partnering is an Ongoing Experiential Activity

The LSN partnering theme is that it is a crucial, ongoing, and experiential activity. LSN believes that partnering cannot be done once or twice a year, as business deals do not work that way. In the life science arena, it can take 9-18 months to put a deal together. This means that all buyers and sellers need a simple, low-cost, straight-forward vehicle to meet and engage monthly in order to find new opportunities for their respective pipelines, advance a conversation, continue to vet and develop a relationship, or close deals. LSN’s recent entrée of digital events has proved and invigorated this concept. Life science is a virtual third-party service domain, making a new, hybrid, global ecosystem timely and compelling. We look forward to advancing life-saving deals through our Healthtech Partnering Weeks, and hope you’ll consider partnering with us. To learn more about sponsorship opportunities, download our sponsorship brochure.

Want to learn more? The business development team at Life Science Nation is available to answer questions and share additional details to help you meet your partnership goals!

International
Greg Mannix
Chief Conference Officer, Vice President International BD
g.mannix@lifesciencenation.com

West Coast (USA)
Candice He
Global Investment Strategist
c.he@lifesciencenation.com
​
East Coast (USA)
Ashley Zborowski
Director of Business Development
a.zborowski@lifesciencenation.com

← Older Entries
Newer Entries →